CRISPR Therapeutics (CRSP) was Smart Insider's stock pick of the week after the company's non-executive Simeon George bought 989,812 shares for $51.5 million on July 16 at $52.03 apiece, while "more than doubling" his stake.
George bought the shares on behalf of SR One Capital Management, where he is the managing partner, Smart Insider said in a Tuesday note.
Their only prior transactions were subscriptions for $931,000 in October 2016 and $75 million in February last year, the note added.
"We are also surprised to see the purchase, assuming the company is in a closed period with their results expected around the 10th of August," according to the note.
Smart Insider ranked the stock +N, or notable & positive signal, on July 18.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.